The effects of melatonin versus placebo on delirium in hip fracture patients: study protocol of a randomised, placebo-controlled, double blind trial
<p>Abstract</p> <p>Background</p> <p>With an ageing population, older persons become a larger part of the hospital population. The incidence of delirium is high in this group, and experiencing delirium has major short- and long-term sequelae, which makes prevention cruc...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2011-07-01
|
| Series: | BMC Geriatrics |
| Online Access: | http://www.biomedcentral.com/1471-2318/11/34 |
| _version_ | 1818447257429606400 |
|---|---|
| author | van Velde Romuald Wolvius Reinder van Rees Carolien Kloen Peter Goslings J van Oosten Hannah E van Munster Barbara C de Jonghe Annemarieke Levi Marcel M Korevaar Joke C de Rooij Sophia E |
| author_facet | van Velde Romuald Wolvius Reinder van Rees Carolien Kloen Peter Goslings J van Oosten Hannah E van Munster Barbara C de Jonghe Annemarieke Levi Marcel M Korevaar Joke C de Rooij Sophia E |
| author_sort | van Velde Romuald |
| collection | DOAJ |
| description | <p>Abstract</p> <p>Background</p> <p>With an ageing population, older persons become a larger part of the hospital population. The incidence of delirium is high in this group, and experiencing delirium has major short- and long-term sequelae, which makes prevention crucial. During delirium, a disruption of the sleep-wake cycle is frequently observed. Melatonin plays an important role in the regulation of the sleep-wake cycle, so this raised the hypothesis that alterations in the metabolism of melatonin might play an important role in the development of delirium. The aim of this article is to describe the design of a randomised, placebo controlled double-blind trial that is currently in progress and that investigates the effects of melatonin versus placebo on delirium in older, postoperative hip fracture patients.</p> <p>Methods/Design</p> <p>Acutely hospitalised patients aged 65 years or older admitted for surgical repair of hip fracture are randomised (n = 452) into a treatment or placebo group. Prophylactic treatment consists of orally administered melatonin (3 mg) at 21:00 h on five consecutive days. The primary outcome is the occurrence of delirium, to be diagnosed according to the Confusion Assessment Method, within eight days after start of the study medication. Secondary outcomes are delirium severity, measured by the Delirium Rating Scale; duration of delirium; differences in subtypes of delirium; differences in total length of hospital stay; total dose of antipsychotics and/or benzodiazepine use during delirium; and in-hospital complications. In the twelve-month follow up visit, cognitive function is measured by a Mini-Mental state examination and the Informant Questionnaire on Cognitive Decline in the Elderly. Functional status is assessed with the Katz ADL index score (patient and family version) and grip strength measurement. The outcomes of these assessments are compared to the outcomes that were obtained during admission.</p> <p>Discussion</p> <p>The proposed study will contribute to our knowledge because studies on the prophylactic treatment of delirium with long term follow up remain scarce. The results may lead to a prophylactic treatment for frail older persons at high risk for delirium that is safe, effective, and easily implementable in daily practice.</p> <p>Trial registration</p> <p>Dutch Clinical Trial Registry: <a href="http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=1576">NTR1576</a></p> |
| first_indexed | 2024-12-14T20:00:45Z |
| format | Article |
| id | doaj.art-b24899c80c98437bafc82b656d24e451 |
| institution | Directory Open Access Journal |
| issn | 1471-2318 |
| language | English |
| last_indexed | 2024-12-14T20:00:45Z |
| publishDate | 2011-07-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Geriatrics |
| spelling | doaj.art-b24899c80c98437bafc82b656d24e4512022-12-21T22:49:10ZengBMCBMC Geriatrics1471-23182011-07-011113410.1186/1471-2318-11-34The effects of melatonin versus placebo on delirium in hip fracture patients: study protocol of a randomised, placebo-controlled, double blind trialvan Velde RomualdWolvius Reindervan Rees CarolienKloen PeterGoslings Jvan Oosten Hannah Evan Munster Barbara Cde Jonghe AnnemariekeLevi Marcel MKorevaar Joke Cde Rooij Sophia E<p>Abstract</p> <p>Background</p> <p>With an ageing population, older persons become a larger part of the hospital population. The incidence of delirium is high in this group, and experiencing delirium has major short- and long-term sequelae, which makes prevention crucial. During delirium, a disruption of the sleep-wake cycle is frequently observed. Melatonin plays an important role in the regulation of the sleep-wake cycle, so this raised the hypothesis that alterations in the metabolism of melatonin might play an important role in the development of delirium. The aim of this article is to describe the design of a randomised, placebo controlled double-blind trial that is currently in progress and that investigates the effects of melatonin versus placebo on delirium in older, postoperative hip fracture patients.</p> <p>Methods/Design</p> <p>Acutely hospitalised patients aged 65 years or older admitted for surgical repair of hip fracture are randomised (n = 452) into a treatment or placebo group. Prophylactic treatment consists of orally administered melatonin (3 mg) at 21:00 h on five consecutive days. The primary outcome is the occurrence of delirium, to be diagnosed according to the Confusion Assessment Method, within eight days after start of the study medication. Secondary outcomes are delirium severity, measured by the Delirium Rating Scale; duration of delirium; differences in subtypes of delirium; differences in total length of hospital stay; total dose of antipsychotics and/or benzodiazepine use during delirium; and in-hospital complications. In the twelve-month follow up visit, cognitive function is measured by a Mini-Mental state examination and the Informant Questionnaire on Cognitive Decline in the Elderly. Functional status is assessed with the Katz ADL index score (patient and family version) and grip strength measurement. The outcomes of these assessments are compared to the outcomes that were obtained during admission.</p> <p>Discussion</p> <p>The proposed study will contribute to our knowledge because studies on the prophylactic treatment of delirium with long term follow up remain scarce. The results may lead to a prophylactic treatment for frail older persons at high risk for delirium that is safe, effective, and easily implementable in daily practice.</p> <p>Trial registration</p> <p>Dutch Clinical Trial Registry: <a href="http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=1576">NTR1576</a></p>http://www.biomedcentral.com/1471-2318/11/34 |
| spellingShingle | van Velde Romuald Wolvius Reinder van Rees Carolien Kloen Peter Goslings J van Oosten Hannah E van Munster Barbara C de Jonghe Annemarieke Levi Marcel M Korevaar Joke C de Rooij Sophia E The effects of melatonin versus placebo on delirium in hip fracture patients: study protocol of a randomised, placebo-controlled, double blind trial BMC Geriatrics |
| title | The effects of melatonin versus placebo on delirium in hip fracture patients: study protocol of a randomised, placebo-controlled, double blind trial |
| title_full | The effects of melatonin versus placebo on delirium in hip fracture patients: study protocol of a randomised, placebo-controlled, double blind trial |
| title_fullStr | The effects of melatonin versus placebo on delirium in hip fracture patients: study protocol of a randomised, placebo-controlled, double blind trial |
| title_full_unstemmed | The effects of melatonin versus placebo on delirium in hip fracture patients: study protocol of a randomised, placebo-controlled, double blind trial |
| title_short | The effects of melatonin versus placebo on delirium in hip fracture patients: study protocol of a randomised, placebo-controlled, double blind trial |
| title_sort | effects of melatonin versus placebo on delirium in hip fracture patients study protocol of a randomised placebo controlled double blind trial |
| url | http://www.biomedcentral.com/1471-2318/11/34 |
| work_keys_str_mv | AT vanvelderomuald theeffectsofmelatoninversusplaceboondeliriuminhipfracturepatientsstudyprotocolofarandomisedplacebocontrolleddoubleblindtrial AT wolviusreinder theeffectsofmelatoninversusplaceboondeliriuminhipfracturepatientsstudyprotocolofarandomisedplacebocontrolleddoubleblindtrial AT vanreescarolien theeffectsofmelatoninversusplaceboondeliriuminhipfracturepatientsstudyprotocolofarandomisedplacebocontrolleddoubleblindtrial AT kloenpeter theeffectsofmelatoninversusplaceboondeliriuminhipfracturepatientsstudyprotocolofarandomisedplacebocontrolleddoubleblindtrial AT goslingsj theeffectsofmelatoninversusplaceboondeliriuminhipfracturepatientsstudyprotocolofarandomisedplacebocontrolleddoubleblindtrial AT vanoostenhannahe theeffectsofmelatoninversusplaceboondeliriuminhipfracturepatientsstudyprotocolofarandomisedplacebocontrolleddoubleblindtrial AT vanmunsterbarbarac theeffectsofmelatoninversusplaceboondeliriuminhipfracturepatientsstudyprotocolofarandomisedplacebocontrolleddoubleblindtrial AT dejongheannemarieke theeffectsofmelatoninversusplaceboondeliriuminhipfracturepatientsstudyprotocolofarandomisedplacebocontrolleddoubleblindtrial AT levimarcelm theeffectsofmelatoninversusplaceboondeliriuminhipfracturepatientsstudyprotocolofarandomisedplacebocontrolleddoubleblindtrial AT korevaarjokec theeffectsofmelatoninversusplaceboondeliriuminhipfracturepatientsstudyprotocolofarandomisedplacebocontrolleddoubleblindtrial AT derooijsophiae theeffectsofmelatoninversusplaceboondeliriuminhipfracturepatientsstudyprotocolofarandomisedplacebocontrolleddoubleblindtrial AT vanvelderomuald effectsofmelatoninversusplaceboondeliriuminhipfracturepatientsstudyprotocolofarandomisedplacebocontrolleddoubleblindtrial AT wolviusreinder effectsofmelatoninversusplaceboondeliriuminhipfracturepatientsstudyprotocolofarandomisedplacebocontrolleddoubleblindtrial AT vanreescarolien effectsofmelatoninversusplaceboondeliriuminhipfracturepatientsstudyprotocolofarandomisedplacebocontrolleddoubleblindtrial AT kloenpeter effectsofmelatoninversusplaceboondeliriuminhipfracturepatientsstudyprotocolofarandomisedplacebocontrolleddoubleblindtrial AT goslingsj effectsofmelatoninversusplaceboondeliriuminhipfracturepatientsstudyprotocolofarandomisedplacebocontrolleddoubleblindtrial AT vanoostenhannahe effectsofmelatoninversusplaceboondeliriuminhipfracturepatientsstudyprotocolofarandomisedplacebocontrolleddoubleblindtrial AT vanmunsterbarbarac effectsofmelatoninversusplaceboondeliriuminhipfracturepatientsstudyprotocolofarandomisedplacebocontrolleddoubleblindtrial AT dejongheannemarieke effectsofmelatoninversusplaceboondeliriuminhipfracturepatientsstudyprotocolofarandomisedplacebocontrolleddoubleblindtrial AT levimarcelm effectsofmelatoninversusplaceboondeliriuminhipfracturepatientsstudyprotocolofarandomisedplacebocontrolleddoubleblindtrial AT korevaarjokec effectsofmelatoninversusplaceboondeliriuminhipfracturepatientsstudyprotocolofarandomisedplacebocontrolleddoubleblindtrial AT derooijsophiae effectsofmelatoninversusplaceboondeliriuminhipfracturepatientsstudyprotocolofarandomisedplacebocontrolleddoubleblindtrial |